Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 5,274 shares, an increase of 77.3% from the August 15th total of 2,975 shares. Based on an average trading volume of 2,250 shares, the short-interest ratio is presently 2.3 days.
Biofrontera Stock Up 1.5%
Shares of NASDAQ BFRIW opened at $0.02 on Thursday. The firm’s 50-day moving average is $0.03 and its 200-day moving average is $0.03. Biofrontera has a 1 year low of $0.02 and a 1 year high of $0.15.
Biofrontera Company Profile
Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.
The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.
Recommended Stories
- Five stocks we like better than Biofrontera
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
